HomeCancer

Cancer

Dr Waks on Key Questions Relating to the First-Line Use of T-DXd in HER2+ Breast Most cancers

Adrienne G. Waks, MD, doctor, affiliate director of Medical Analysis, Dana-Farber Most cancers Institute, teacher in medication, Harvard Medical Faculty, discusses key questions...

Actual Sciences Awards Grants to twenty-eight Organizations Targeted on Growing Colorectal Most cancers Screening

Since its launch in 2022, the FOCUS Program has awarded greater than $4.5 million to over 75 organizations all through the USMADISON, Wis.,...

Circulating Tumor DNA Can Assist Personalize Immunotherapy Remedy for Inoperable NSCLC

Examine Investigates How ctDNA Might Assist Personalize Immunotherapy Remedy for Inoperable NSCLCJuly 17, 2024

Dolphins Most cancers Problem and StacheStrong Partnership Advances Mind Most cancers Analysis at Sylvester Complete Most cancers Middle

By: Stacey Bomser | July 17, 2024 | 5 min. learn |  Share A $1 million dedication helps glioblastoma research at Sylvester Mind Tumor...

Hot Topics